PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.





YEAR: 2005




CATEGORY: Contraception (Birth Control) and Family Planning



TITLE



A comparative study of monophasic oral contraceptives containing either

drospirenone 3 micrograms or levonorgestrel 150 micrograms on premenstrual

symptoms.



AUTHORS

Sangthawan M; Taneepanichskul S


SOURCE

Contraception. 2005;71:1-7.



ABSTRACT

This open-label randomized study compared the effects of two combined oral contraceptives (OCs) containing 3 mg

drospirenone (DRSP)/30 µg ethinyl estradiol (EE) with 150 µg levonorgestrel (LNG)/30 µg EE on the prevalence and

changes from baseline of premenstrual symptoms after six cycles. The symptoms were measured using the

Women's Health Assessment Questionnaire. Subjects receiving DRSP/EE had fewer prevalence of premenstrual

symptoms than those receiving LNG/EE after six cycles. A significantly lower score of negative affect category in the

premenstrual phase was demonstrated in those receiving DRSP/EE more than LNG/EE. The DRSP/ EE group

showed a greater improvement of mean scores from baseline in the premenstrual phase compared with those who

received LNG/ EE on negative affect as seen in the items on anxiety, irritability, feeling sad or blue and weight gain in

the category of water retention. In conclusion, OCs containing DRSP have beneficial effects in reducing the

prevalence of premenstrual symptoms especially the symptoms of negative affect and weight gain, particularly when

compared to LNG/EE. Hence, it should be recommended for women who are susceptible to these adverse

symptoms. (PubHealth.info Document ID: CONT1T 87-06)



PubHealth.info NOTE: The author(s) of this article titled, "A comparative study of monophasic oral contraceptives

containing either drospirenone 3 micrograms or levonorgestrel 150 micrograms on premenstrual symptoms.", is(are)

Sangthawan M; Taneepanichskul S. The source of this article is "Contraception. 2005;71:1-7.". This article was

published in 2005 in English language(s). (PubHealth.info® Document ID: CONT1T 87-06. All rights reserved with

PubHealth.info) PIN: 87


This article is peer-reviewed.




 

 

Web

PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.